Published in Oncotarget on January 26, 2016
Peritoneal carcinomatosis: limits of diagnosis and the case for liquid biopsy. Oncotarget (2017) 0.79
MicroRNA biogenesis and their functions in regulating stem cell potency and differentiation. Biol Proced Online (2016) 0.79
MicroRNA in Metabolic Re-Programming and Their Role in Tumorigenesis. Int J Mol Sci (2016) 0.77
Regulation of CTNNB1 signaling in gastric cancer and stem cells. World J Gastrointest Oncol (2016) 0.77
miR-24-3p Suppresses Malignant Behavior of Lacrimal Adenoid Cystic Carcinoma by Targeting PRKCH to Regulate p53/p21 Pathway. PLoS One (2016) 0.77
Differentially expressed miRNAs in triple negative breast cancer between African-American and non-Hispanic white women. Oncotarget (2016) 0.75
18β-glycyrrhetinic acid suppresses gastric cancer by activation of miR-149-3p-Wnt-1 signaling. Oncotarget (2016) 0.75
Role of miR-647 in human gastric cancer suppression. Oncol Rep (2017) 0.75
MicroRNA Expression Patterns of CD8+ T Cells in Acute and Chronic Brucellosis. PLoS One (2016) 0.75
Recombinant human bone morphogenetic protein-2 inhibits gastric cancer cell proliferation by inactivating Wnt signaling pathway via c-Myc with aurora kinases. Oncotarget (2016) 0.75
Silencing of miR-1247 by DNA methylation promoted non-small-cell lung cancer cell invasion and migration by effects of STMN1. Onco Targets Ther (2016) 0.75
MiR-570 inhibits cell proliferation and glucose metabolism by targeting IRS1 and IRS2 in human chronic myelogenous leukemia. Iran J Basic Med Sci (2017) 0.75
Prognostic value of microRNAs in gastric cancer: a meta-analysis. Oncotarget (2017) 0.75
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer (2010) 90.16
The functions of animal microRNAs. Nature (2004) 64.85
Prediction of mammalian microRNA targets. Cell (2003) 53.70
Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer (2006) 46.47
Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol (2008) 4.44
Incidence and mortality of gastric cancer in China. World J Gastroenterol (2006) 4.00
miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest (2008) 2.87
Oncogenic transformation by the signaling adaptor proteins insulin receptor substrate (IRS)-1 and IRS-2. Cell Cycle (2007) 2.48
Treatment of gastric cancer. World J Gastroenterol (2014) 1.93
MiR-148a attenuates paclitaxel resistance of hormone-refractory, drug-resistant prostate cancer PC3 cells by regulating MSK1 expression. J Biol Chem (2010) 1.66
Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance. J Gastrointest Surg (2010) 1.63
Current status and future perspectives in gastric cancer management. Cancer Treat Rev (2000) 1.54
Clinicopathological and prognostic significance of PDCD4 and microRNA-21 in human gastric cancer. Int J Oncol (2010) 1.39
Molecular pathology of gastric cancer: research and practice. Pathol Res Pract (2011) 1.39
MiR-148a promotes apoptosis by targeting Bcl-2 in colorectal cancer. Cell Death Differ (2011) 1.33
miR-148a promoted cell proliferation by targeting p27 in gastric cancer cells. Int J Biol Sci (2011) 1.33
Dysregulation of microRNA biogenesis and gene silencing in cancer. Sci Signal (2015) 1.31
The clinical significance of MiR-148a as a predictive biomarker in patients with advanced colorectal cancer. PLoS One (2012) 1.26
Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation. Oncol Rep (2011) 1.23
miR-148a plays a pivotal role in the liver by promoting the hepatospecific phenotype and suppressing the invasiveness of transformed cells. Hepatology (2013) 1.22
miR-148a is an androgen-responsive microRNA that promotes LNCaP prostate cell growth by repressing its target CAND1 expression. Prostate Cancer Prostatic Dis (2010) 1.18
MicroRNA-29c mediates initiation of gastric carcinogenesis by directly targeting ITGB1. Gut (2014) 1.17
A systematic review of microRNA expression profiling studies in human gastric cancer. Cancer Med (2014) 1.14
Characterization of microRNA-29 family expression and investigation of their mechanistic roles in gastric cancer. Carcinogenesis (2013) 1.11
MiR-361-5p acts as a tumor suppressor in prostate cancer by targeting signal transducer and activator of transcription-6(STAT6). Biochem Biophys Res Commun (2014) 1.06
The role of miR-148a in gastric cancer. J Cancer Res Clin Oncol (2014) 1.03
The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis. Gut (2015) 1.03
Down-regulation of miR-126 is associated with colorectal cancer cells proliferation, migration and invasion by targeting IRS-1 via the AKT and ERK1/2 signaling pathways. PLoS One (2013) 0.98
Prognostic role of microRNA-21 in gastric cancer: a meta-analysis. Med Sci Monit (2014) 0.98
IRS1 is highly expressed in localized breast tumors and regulates the sensitivity of breast cancer cells to chemotherapy, while IRS2 is highly expressed in invasive breast tumors. Cancer Lett (2013) 0.98
MicroRNA-145 suppresses hepatocellular carcinoma by targeting IRS1 and its downstream Akt signaling. Biochem Biophys Res Commun (2014) 0.97
MiR-148a regulates MEG3 in gastric cancer by targeting DNA methyltransferase 1. Med Oncol (2014) 0.95
GPER mediated estradiol reduces miR-148a to promote HLA-G expression in breast cancer. Biochem Biophys Res Commun (2014) 0.91
Novel evidence for an oncogenic role of microRNA-21 in colitis-associated colorectal cancer. Gut (2015) 0.91
The rescue of miR-148a expression in pancreatic cancer: an inappropriate therapeutic tool. PLoS One (2013) 0.89
MicroRNA-361-5p facilitates cervical cancer progression through mediation of epithelial-to-mesenchymal transition. Med Oncol (2013) 0.88
MiR-148a regulates the growth and apoptosis in pancreatic cancer by targeting CCKBR and Bcl-2. Tumour Biol (2013) 0.88
Insulin receptor substrate 1/2 (IRS1/2) regulates Wnt/β-catenin signaling through blocking autophagic degradation of dishevelled2. J Biol Chem (2014) 0.88
Decreased expression and clinical significance of miR-148a in hepatocellular carcinoma tissues. Eur J Med Res (2014) 0.87
MicroRNA and signaling pathways in gastric cancer. Cancer Gene Ther (2014) 0.86
Chemotherapy-Induced miRNA-29c/Catenin-δ Signaling Suppresses Metastasis in Gastric Cancer. Cancer Res (2015) 0.84
miR-148a dependent apoptosis of bladder cancer cells is mediated in part by the epigenetic modifier DNMT1. Mol Carcinog (2015) 0.82
miR-214: a potential biomarker and therapeutic for different cancers. Future Oncol (2015) 0.82
Deregulation between miR-29b/c and DNMT3A is associated with epigenetic silencing of the CDH1 gene, affecting cell migration and invasion in gastric cancer. PLoS One (2015) 0.81
Glabridin inhibits cancer stem cell-like properties of human breast cancer cells: An epigenetic regulation of miR-148a/SMAd2 signaling. Mol Carcinog (2015) 0.79
MiR200c targets IRS1 and suppresses prostate cancer cell growth. Prostate (2015) 0.79